News - Page 5

As geopolitics bring reshoring interest to a fever pitch, the United States Pharmacopeia (USP) is adding to the impetus for local drug production with a warning that homes in on the pharmaceutical

Japan’s Shionogi is joining the spate of drugmakers to unveil a U.S. manufacturing commitment, albeit under slightly different circumstances than its peers.

Adragos Pharma, a German CDMO, snapped up one of Europe’s largest sterile injectables production plants for an undisclosed price from Sanofi.

“You want to be holistic, but within a particular specialty,” Ardena CEO Jeremie Trochu recently told Fierce about how the CDMO is navigating rough geopolitical waters.

Amid a major corporate overhaul, Novo Nordisk is pruning the ranks at its Bloomington, Indiana, production facility, which contributes to the blockbuster GLP-1 medications Ozempic and Wegovy.

BASF Pharma Solutions will raise its prices by up to 20% for its excipients and some of its active pharmaceutical ingredients, effective immediately.

The FDA has delayed its target decision date for Orca Bio’s blood cancer cell therapy candidate Orca-T by three months to July 6 after the company submitted additional CMC-related data.

The labor union of Samsung Biologics has secured the votes needed to strike, signaling a potential escalation in an impasse over what the union has branded “[u]nresolved governance failures and rigid labor

The new company, looking to eliminate costly manufacturing bottlenecks by producing biologic medicines in chicken eggs, has now lined up a commercial taker.

With key expansions coming to fruition on either side of the pond, specialist CDMO Hovione is making sure that drugmakers can access its particle engineering expertise across multiple geographies.